Table 8.
GSRS scores in the CKD group (13 S and 10 P).
T0 | T2 | T3 | p-Value Between Time Points | ||
---|---|---|---|---|---|
GSRS 6 | P | 2.40 ± 0.41 | 2.20 ± 0.51 | 2.00 ± 0.32 | - |
S | 2.38 ± 0.34 | 2.08 ± 0.41 | 1.46 ± 0.23 * | 0.04 | |
GSRS 13 | P | 2.20 ± 0.76 | 1.40 ± 0.38 | 1.40 ± 0.38 | - |
S | 2.23 ± 0.27 | 1.15 ± 0.15 * | 1.31 ± 0.20 * | <0.004 | |
Abdominal pain | P | 4.00 ± 0.58 | 4.40 ± 0.75 | 3.40 ± 0.25 | - |
S | 4.85 ± 0.51 | 3.54 ± 0.28 * | 3.62 ± 0.34 | 0.03 * | |
Constipation syndrome |
P | 5.00 ± 0.69 | 4.00 ± 0.58 | 4.40 ± 0.64 | - |
S | 6.08 ± 0.80 | 3.77 ± 0.41* | 4.23 ± 0.71 | 0.02 * |
Only GSRS items and domains showing statistically significant changes after the treatment (items 4, 6 and 13, abdominal pain, indigestion syndrome and constipation syndrome) are shown. * p < 0.05 vs. T0. Data are expressed as mean ± SEM, differences tested by Kruskal–Wallis multiple-comparison z-value test.